A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The main purpose of this study is to evaluate the efficacy and safety of the study drug known as baricitinib in participants with systemic lupus erythematosus.
Epistemonikos ID: a11e56057ec0a0adf7d1dcdc1fd7839fa62c57b0
First added on: May 12, 2024